Infosys share price jumps 4.61% to ₹1,161.20 on October 16
Anupama VM
- 0 min read
Last Updated: 16th October 2026 - 05:18 pm
Key Takeaways
- Infosys advanced ₹51.20 or 4.61% to ₹1,161.20 and finished just ₹6.80 below the session high of ₹1,168.
- Trading volume reached 27.71 million shares, while the closing price was above the 50-day and 100-day DMAs but below the 200-day DMA.
- One- and three-month returns were both close to 8%, while six-month and one-year performance remained negative.
Infosys share price recorded one of the larger Nifty 50 advances on October 16, closing at ₹1,161.20. The gain was ₹51.20, or 4.61%. Infosys opened at ₹1,128 against a previous close of ₹1,110 and moved between ₹1,122 and ₹1,168. The stock ended just ₹6.80 below the session high and ₹39.20 above the low.
From open to close, the share advanced ₹33.20. Volume was substantial at 27,710,761 shares, while market capitalisation stood at ₹4,71,247 crore.
The closing price moved above two of the three cited moving averages. Infosys' 50-day DMA was ₹1,069.20, putting the close ₹92 higher. The 100-day DMA stood at ₹1,114.40, leaving a ₹46.80 positive gap. The 200-day DMA remained higher at ₹1,211.60, with Infosys closing ₹50.40 below that reference.
Across the past 52 weeks, the stock traded from ₹980 to ₹1,728. The October 16 close was ₹181.20 above the low and ₹566.80 below the high.
Shorter-period returns were positive. Infosys recorded 7.82% over one month and 7.89% over three months. The six-month return remained -11.04%, while the one-year figure was -21.24%. The October 16 advance therefore strengthened the shorter-period numbers, with the stock combining a 4.61% daily gain, high turnover and a closing position near the top of its ₹46 intraday range.
Frequently Asked Questions
What was the Infosys share price on October 16?
Was Infosys above its 200-day DMA?
How much Infosys volume was traded?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.